Clemastine in Cardiovascular Surgery

Status Completed

Clinical Trial Summary

In this study, a prospective, randomized, double-blind pilot trial designed to evaluate the effect of histamine H1 receptor antagonist clemastine on perioperative anaphylaxis in cardiovascular surgery with cardiopulmonary bypass, especially for the efficacy and safety on reducing heparin and protamine associated anaphylaxis.

Clinical Trial Description

Study Design

Related Conditions & MeSH terms

Efficacy and Safety

Clinical Trial Details

NCT number	NCT03826004
Study type	Interventional
Source	Chinese Academy of Medical Sciences, Fuwai Hospital
Contact
Status	Completed
Phase	N/A
Start date	February 20, 2019
Completion date	January 10, 2020

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04759534` - Application of PCSK9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia	Phase 3
Not yet recruiting	`NCT05532111` - Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial	N/A
Active, not recruiting	`NCT04284215` - Efficacy and Safety of Albumin Paclitaxel Combined With Cisplatin Chemoradiotherapy for Non-resectable Stage III NSCLC	N/A
Completed	`NCT06202456` - A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver	Phase 4
Completed	`NCT04870606` - Proxalutamide (GT0918) Treatment for Outpatients With Mild or Moderate COVID-19 Illness	Phase 3
Completed	`NCT03660761` - Apatinib in Recurrent or Refractory Intracranial Central Nervous System Malignant Tumors	Phase 2
Active, not recruiting	`NCT03794778` - Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer	Phase 4
Recruiting	`NCT03255343` - Treatment of Non-responding to Conventional Therapy Inoperable Liver Cancers by in Situ Introduction of ImDendrim	N/A
Recruiting	`NCT04197544` - Evaluation of the Implantation of the End-vascular Creation of the Arteriovenous Fistulas in Patients in the University Hospital of Araba. Pilot Study.	N/A
Recruiting	`NCT04518501` - Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer	Phase 1/Phase 2
Completed	`NCT03779776` - The Efficacy and Safety of Early Vitamin AD Supplementation in Very Preterm Infants	N/A
Not yet recruiting	`NCT06218004` - Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma	Phase 2
Enrolling by invitation	`NCT02809079` - Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese Patients	Phase 4
Active, not recruiting	`NCT06194188` - A Phase 2 Clinical Study of CU-20401	Phase 2
Recruiting	`NCT03901235` - MSC Intratissular Injection in Crohn Disease Patients	Phase 1/Phase 2
Active, not recruiting	`NCT03623776` - Neoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.	Phase 2
Recruiting	`NCT04078399` - Efficacy and Safety of Azacitidine Combined With Interferon in the Treatment of Post-transplant Recurrence	N/A
Not yet recruiting	`NCT06351735` - Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis
Not yet recruiting	`NCT06383078` - HR070803 in Combination With Oxaliplatin, S-1 Versus NALIRIFOX as Adjuvant Therapy for Pancreatic Cancer	Phase 2
Withdrawn	`NCT05481775` - Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer	Phase 2